Allbright assists CF Pharm Tech, Inc. in completing RMB 440 million D-round financing

In August, 2017, CF PharmTech, Inc. successfully completed the D-round financing in amount of RMB 440 million.

Allbright Lawyers Provided Comprehensive Legal Services to United Arab Shipping Company Anti-Trust Matters

Leo Zheng Shared his Perspectives at the HK Filmart Party, Co-Hosted by AllBright

AllBright Advised Ceva, a French Company, in Completing the Acquisition of a Well-Known Animal Vaccine Manufacturer in China

All Bright Law Offices Successfully Completed an Anti Trust Filing at MOFCOM for Its Client

AllBright assisted Albemarle Corporation in completing acquisition of premium lithium salts businesses in China

AllBright-advised Kersen IPO Application is given the green light by Main Board Public Offering Review Committee of CSRC

AllBright advises “Anysoft Information” on its IPO of A Shares and Listing on Shenzhen Stock Exchange

AllBright advises Shanghai Fosun Pharmaceutical (Group) Co., Ltd. on its 2015 private placement of A Shares

AllBright stops the 1st anti-subsidy investigation by Turkey against China and escorts for Chinese steel enterprises abroad